Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae

被引:23
作者
Narita, Mitsuo
Tanaka, Hiroshi
机构
[1] Sapporo Tetsudo JR Hosp, Dept Pediat, Chuo Ku, Sapporo, Hokkaido 0600033, Japan
[2] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido, Japan
关键词
D O I
10.1002/ppul.20445
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:397 / 397
页数:1
相关论文
共 4 条
[1]   Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children [J].
Lee, KY ;
Lee, HS ;
Hong, JH ;
Lee, MH ;
Lee, JS ;
Burgner, D ;
Lee, BC .
PEDIATRIC PULMONOLOGY, 2006, 41 (03) :263-268
[2]   Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon [J].
Narita, M ;
Tanaka, H ;
Abe, S ;
Yamada, S ;
Kubota, M ;
Togashi, T .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) :909-914
[3]   Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection [J].
Narita, M ;
Tanaka, H ;
Yamada, S ;
Abe, S ;
Ariga, T ;
Sakiyama, Y .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) :1028-1030
[4]   Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults [J].
Tanaka, H ;
Narita, M ;
Teramoto, S ;
Saikai, T ;
Oashi, K ;
Igarashi, T ;
Abe, S .
CHEST, 2002, 121 (05) :1493-1497